It is well established that MHC-restricted T cell responses decisively influence the outcome of virus infection (1-3). In the rejection of murine leukemia virus-induced lymphomas, Th and cytotoxic T (Tc) t cells are considered essential effector cells, besides the effects of MuLVspecific antibodies, which can neutralize the virus and inhibit its spread (reviewed in reference 4). Many attempts have been made to characterize the viral antigens that are important in recognition by murine leukemia virus (MuLV)-specific T cells. The presence of viral proteins on the cell surface of MuLV induced tumor cell lines has been documented in a number of serological studies. These cell surface viral proteins, which in processed form are potential target molecules for recognition by Th and Tc cells (5), include the viral env gene-encoded products gPr85env, gp70, and p15(E) and the gag gene-encoded gP95g°g, gP85g°g, p10, pp12, p30, and p15 (reviewed in reference 6). In addition to this, recent data indicate that viral proteins that are not detectable at the surface of cells by serology can also serve as targets for T cells (7). DNA-mediated gene transfer experiments, in which single MuW viral antigens together with particular MHC class I antigens were expressed in heterologous cell lines, and the availability of Tc clones have provided a more subtle analysis of MHC and viral antigen recognition (8, 9). A highly complex picture emerged from these studies, which collectively indicate that both MHC and non-MHC genes determine which viral antigens are recognized in the context of MHC.
MuLVinduced lymphomagehesis results from a complex series ofoncogenic events in virus-infected cells (18) The development of lymphomas is strongly influenced by the H-2 complex, which probably reflects the fact that virus-infected cells will not grow out to overt lymphomas in the presence of H-2-restricted MuLVspecific Th and Tc responses. However, T cell immunosurveillance will fail if tumor cells do not express the relevant MHC and/or viral peptide at the cell surface. Indeed, various examples have been described of so-called virus-negative variant murine lymphoma cell lines that appeared to be resistant against T cell effector mechanisms . These variants, however, all arose in rather artificial situations, e.g., long-term in vitro culture of tumor cells (19) or under selective pressure of exogenously added Tc therapy (20) . The important role ofclass I MHC gene expression in more natural conditions, i.e., in tumorigenesxs and metastasis, follows from a number of studies (21, 22) . Low surface expression of class I MHC antigens in MuLVinduced lymphomas has been observed incidentally, e.g., on an AKR thymoma-derived cell line (22) , certain radiation leukemia virus-induced lymphomas (23) , and Moloney MuLV (MoMuLV)-induced T cell lymphomas (24) .
We are interested in the in vivo biological relevance of the proposed selection mechanisms for tumor cells with respect to viral antigen and MHC cell surface expression. We previously described that the H-2 complex strongly influences lymphoma incidence after neonatal infection of C57BL/10 and C57BL/6 mice with mink cell focus-inducing (MCF) MuLV, MCF 1233 virus (25) . T cell tumor resistance is dominant, maps to the class II MHC-encoding I-A region, and is associated with high titers ofanti-MuLV antibodies, which develop in the presence ofan adequate I-A-regulated antiviral Th response. 64% of animals of susceptible, so-called nonresponder strains (H-2 I-Al , d) developed T cell lymphomas (mean latency, 37 wk). In contrast, only 14% of resistant, so-called responder stains (H-2 I-Ab,bmt2,b/k) developed T cell lymphomas, the mean latency of which (57 wk) was significantly longer. We decided to compare the antigenic profiles, including both viral antigens and MHC antigens, of the many MCF 1233 MuLVinduced T cell lymphomas that arose in the absence of a MHC class II-regulated immune response with those of the few T cell lymphomas that came up in spite of the presence of a good class II-regulated immune response, reasoning that the latter lymphomas, in contrast to the former, were subjected to strong immunoselective pressure.
Our results show indeed the absence ofparticular env and/or gag proteins, or more rarely of particular MHC class I antigens on the cell surface of all responder T cell lymphomas tested, in sharp contrast to the abundant expression of both env and gag proteins and MHC antigens on nonresponder T cell lymphomas. Additionally, in a limited study surface, expression differences were confirmed at the RNA level .
Materials and Methods
Mice, Virus, and Lymphomas. Primary lymphomas were induced by injection of newborn mice ofC57BL/10 or C57BL/6 background, carrying various H-2 haplotypes as listed in Table  1 , with MCF 1233 MuLV as described (25) . The origin and characteristics of MCF 1233 were described previously (26) . This dualtropic B-tropic MuLV was biologically cloned from a T cell tumor, which arose in a B10.A mouse after milk transmission of a naturally occurring B-tropic ecotropic MuLV (27) . At autopsy ofmoribund mice, affected lymphoid organs were removed and handled in three ways . For histologic evaluation, part of the tumor was fixed in formalin (10% in PBS) . Part of the tumor was cryopreserved as a viable cell suspension in liquid nitrogen in 10°Jo DMSO as described previously (28) . The remainder of the tumor tissue was frozen in liquid nitrogen and stored at -70°C for DNA and RNA isolation procedures. Lymphomas were classified according to combined phenotypic, histologic, and genotypic criteria as described (29) . In vivo passages of lymphomas were carried out by intraperitoneal inoculation of 5-10 x 106 viable cells recovered after thawing of cryopreserved tumor cell suspensions . C57BL/10,B6.C-H-2 6-14 and C57BL/6 .Kh nu/nu mice used in transplantation experiments were obtained from the animal department ofthe Netherlands Cancer Institute, Amsterdam .
Immunofluorescence Studies. After thawing, tumor cell suspensions were incubated at 37°C for 2.5 h in Iscove's modified Dulbecco medium supplemented with 10% heat-inactivated FCS, penicillin (100 Wg/ml), kanamycin (100 kg/ml), glutamine (2 mM), and 2-ME (20 p.M). To remove nonviable cells and erythrocytes, we centrifuged 2 ml of cell suspension (containing a maximum of 108 cells) at 1,000 g for 15 min on a 4-ml cushion of Ficoll-Hypaque (1.079 g/cm3). Consistently, >90% of tumor cells recovered this way were viable . In vivo passaged lymphomas were tested either directly ex vivo or after thawing of cryopreserved cells as described above.
Membrane Fluorescence.
After washing, cells were resuspended in cytofluorography buffer (CFG buffer: PBS with 2% BSA and 0.1% sodiumazide) . We used mAbs against Thy-1 (59 AD2.2), Lyt-2 (53-6.7) (30), L3T4 (H129.19) (31), and Pgp-1 (142/5) (32). The following anti-MHC mAbs were used: B8.3.24 (anti H-2K b,bm1) (33), Cl 11.4.1 (anti H-2Kk) (34), 27-11-13 (anti H-2Db , d.bmi4) (35) , and 17/227R7 (anti H-2 I-Ab,k.d) (36) . mAb 35/56, a rat IgG2a antibody derived from hybridoma C2346, reacts with the highly conserved gp70' epitope, expressed by ecotropic and MCF MuLV virions, and on ecotropic or MCF MuLVinfected cells (37, 38) . mAb 19-F8, a mouse IgG2b antibody derived from hybridoma C2429, reacts with the highly conserved p15(E)1 epitope, expressed by ecotropic and MCF MuLV virions and on ecotropic or MCF MuLVinfected cells (39) . Hy-13, a mouse IgM antibody, reacts with a conformational determinant formed by the gp70-pl5(E) complex, and with the env precursor polyprotein gPr85e"°of MCF MuLV which are both expressed on MCF MuLVinfected cells (40) . The origins and characteristics of these antiviral mAbs have been described in detail (37) (38) (39) (40) . The polyclonal goat serum prepared against p30 protein of Rauscher MuLV was obtained from the Viral Oncology Program of the National Cancer Institute (Bethesda, MD) . Both ecotropic and MCFgag antigens are detected by this serum, as the gag region is highly conserved between ecotropic and MCF MuLV (reviewed in reference 6).
We incubated 2 x 105 cells with 25 pl antibody for 30 min at 4°C. After washing once in CFG buffer, 25 jal of a second antibody was added, followed by an incubation of 30 min at 4°C. As second antibodies, the following FITC-labeled antisera were used: rabbit anti-rat Ig (1 :30; Organon Teknika, Malvern, PA), goat anti-mouse Ig (1 :20 ; Central Laboratory of the Blood Transfusion Service [CLB], Amsterdam), and rabbit anti-goat Ig (1 :20 ; CLB). After two additional washsteps the tumor cells were analyzed for fluorescence on a FACScan (Becton Dickinson & Co., Mountain View, CA) fitted with a four-decades logarithmic amplifier. All cell populations were at least 75% viable as determined by trypan blue uptake and low-angle light scatter at the time of fluorescence. Nonviable cells were gated out.
BFA Fixation of Tumor Cells and Fluorescence Studies on Intracellular Antigens. After washing, 1-5 x 106 cells were resuspended in 1 ml of freshly prepared buffered formaldehyde acetone (BFA) (1.12 mM Na2HP04, 7.35 mM KH2PO4, 45% vol/vol acetone, 9.25% vol/vol formaldehyde (37%), pH 7.3) for 2 s at room temperature . Subsequently, 5 ml Iscove's medium supplemented as described above were added. After two wash steps in chilled PBS supplemented with 20% human pool serum (HPS), 2 x 105 cells per sample were stained as described for membrane fluorescence studies, however, 50 p,l of antibody supplemented with 20% HPS was used per sample and wash steps were carried out in PBS with 20% HPS . Fluorescence analyses with the FACScan were performed as described for membrane fluorescence analyses .
Removal of Cell Surface Antigens by Trypsin Digestion. Cells were washed once in PBS and subsequently preincubated at a concentration of 2 x 106 cells/ml in PBS at 37°C for 5 min. Then an equal volume oftrypsin (17 .5 U/ml in PBS) was added. Digestion at 37°C was stopped at various timepoints by adding chilled Iscove's medium supplemented with 10% vol/vol BSA, penicillin (100 hg/ml), kanamycin (100 ttg/ml), glutamine (2 mM), and 2-ME (20 /AM) . After two washsteps in supplemented Iscove's medium, the trypsin-treated cells were divided into two portions: cells were stained either for membrane immunofluorescence or, after an additional BEA fixation step, for intracellular fluorescence as described .
DNA and RNA Analyses . Cellular DNAs were isolated and analyzed by Southern blotting as described (29) . Restriction enzymes were used as described by the manufacturer (Boehringer Mannheim Biochemicals, Indianapolis, IN) .
For RNA isolation, frozen tissues were homogenized with a polytron (1 min, full speed) at 0°C in 3 M LiCl, 6 M urea, and maintained overnight at 0°C . After centrifugation (4°C, 10,000 g, 60 min) the pellet was dissolved in 2 ml of 10 mM Tris.Cl, pH 7.4, supplemented with 50 wg/ml proteinase K and 0.5% wt/vol SDS and incubated at 37°C for 30 min . Then, 2 ml of fenol equilibration buffer solution (0.1 M NaCl; 10 mM Tris.Cl, pH 9.0; 0.5170 wt/vol SDS; 5 mM EDTA) were added . Subsequently the RNA was deproteinized by two successive phenol/chlorophorm/isoamylalcohol (50:48 :2) and two chlorophorm/isoamylalcohol (99:1) extractions and precipitated in 0.3 M NaAc by adding 2.5 vol of ethanol (-20°C). Northern blot analysis of RNA with formaldehyde-treated 0.8 0/c agarose gels was performed as described (21) .
Probes were nick translated with 12 P-dCTP to specific activities of 7-8 x 108 cpm/Feg . The isolation and characterization ofthe MuLVspecific hybridization probes have been described (41) (42) (43) . Probes corresponding to the middle and COOH-terminal region ofp15E ofecotropic AKV MuLV (MCp15E probe), the U3LTR of ecotropic AKV MuLV (AKVLTR probe), the NH2-terminal part of the gp70 region of ecotropic AKVMuLV (eco gp70 probe), and the NH2-terminal part of the gp70 region of MCF-MuLV (MCF gp70 probe) were used. The MoVl-gag probe, corresponding to the gag region ofMoMuLV, was obtained by isolating the .5-3.4 Kpnl fragment of MoMuLV clone la (44; courtesy of Dr. A. Berns, Netherlands Cancer Institute) . These MuLV hybridization probes are schematically listed in Fig . 1 , in which their ecotropic and/or MCF specificities are given as well.
The y actin probe, a hamster cDNA, was a gift of Dr. R. Nusse, Netherlands Cancer Institute. The N-myc probe was a 3.1-kb Pst-1 fragment of the mouse N-myc gene (courtesy of Dr. A. Berns) .
TCR (3 chain probes 86T5, hybridizing to the constant regions, and J15, hybridizing to the J/32-C02 intron, have been described previously (29) .
Results
Viral env and gag Antigen Tumor Cell Surface Expression. Primary T cell lymphomas of both H-2 I-A' (nonresponder) mice (n = 17) and H-2 I-Ab, bik (responder) mice (n = 11) were analyzed in membrane immunofluorescence experiments for the cell surface expression of MuLV env and gag antigens. We previously documented that the H-2 I-A k (nonresponder) strains 1310 .A, B10.A(2R), and B10.A(4R) are equally susceptible to T cell lymphoma induction by neonatal infection with MCF 1233 MuLV (T lymphoma incidence 64%, mean latency 37 wk). H-2 I-Ab , bik (responder) strains 1310, B10.A(5R), (1310 x B10 .A)Fi, B6, bm1, and bm14 are relatively resistant to MCF1233-induced T cell lymphomagenesis (T lymphoma incidence 14%, mean latency 57 wk) (25) . In the present study, nonresponder tumors were randomly chosen out of a large panel of nonresponder tumors, whereas all responder tumors that were available have been tested . Tables I and II summarize the data obtained for the two series of lymphomas . A polyclonal goat anti-p30 serum (reactive with p30 and its precursor polyproteins) was used in addition to a panel of mAbs reactive with env proteins: anti-gp70f mAb 35/56, and anti-p15E" mAb 19-F8 react with a highly conserved gp70 and p15E epitope, respectively. These epitopes are expressed by both MCF and ecotropic virions and on the cell surface ofMCF and ecotropic virus-infected cells (37) (38) (39) . The anti-gp70-pl5(E) mAb Hy-13 reacts with an epitope formed by the gp70-pl5E complex of MCF MuLV (40) .
A high percentage (90-100%) of the lymphoma cells of all nonresponder T lymphomas (n = 17), which arose in the absence of a demonstrable antiviral antibody response, showed bright fluorescence with both env-and gag-specific antiviral sera (Table I ) . All nonresponder T cell lymphomas stained with the anti-gp70f mAb (35 :56) and the anti-p15(E)c mAb (19-F8) . Two tumors (2554 and 2594) lacked the expression of the Hy-13-reactive MCFenv determinant. An additional test with a panel of anti-gp70 mAbs (anti-gp70 a-e) (39) indicated that these Hy-13-tumors expressed various ecotropic gp70 determinants (data not shown) .
In the responder T cell lymphomas (n = 11) a different picture was found (Table   11) . 6 of 11 tumors tested did not express gag antigens at the cell surface, as concluded from the complete absence of membrane fluorescence after incubation with the polyclonal anti-p30 serum. On one of these six gag-negative lymphomas (2769), hardly any envelope viral antigens were detected ; only the anti-gp70e mAb was weakly positive (data not shown). One tumor (2498) showed minimal gag expression, and, moreover, lacked the gp70 f epitope (which was ubiquitously found on the nonresponder lymphomas) . Three lymphomas (2875, 2402, and 2810) that did express gag did not express the gp70f epitope. The last tumor of this series of responder T cell lymphomas (2558) was the only one to express both gp70 f env and gag antigens, but, as will be discussed below, this very lymphoma lacked H-2 class I K expression .
When tested for the expression of the Hy-13-reactive gp70/p15E determinant, only two responder T cell lymphomas (2498, gp70 f-negative and 5045, p30-negative) showed bright fluorescence, one tumor (2558) All lymphomas stained strongly positive for Thy-1 antigen expression . Both double-positive (L3T4', Ly-2' ) and helper phenotype (L3T4', Ly-2 -) lymphomas were observed . l The intensity of fluorescence staining of lymphoma cells observed with virus-or MHC-specific antisera (as described in detail in Materials and methods) was related to the intensity of fluorescence observed when control stained, For each individual lymphoma, negative controls constituted lymphoma cells incubated first with indifferent culture supernatant or mouse ascites, followed by a second incubation step with an appropriate FITC-labeled anti-Ig serum . In case of p30 (tested with a polyclonal goat antiserum) normal goat serum was used in the fast incubation as a negative control . The observed staining intensity was quantified as follows . Negative control, mean fluorescence intensity k, standard deviation of the mean s . Fluorescence score for virus or MHC antigen expression : 3, strongly positive ; mean fluorescence intensity > El + 4 s ; 2, positive ; to + 2 s < mean fluorescence intensity < IL + 4 s ; 1, weakly positive ; ji + s < mean fluorescence intensity 4 A + 2 s ; 0, negative ; mean fluorescence intensity < A + s .
reactive mAb was somewhat more heterogeneous, but in general, only dull fluorescence was seen when compared with nonresponder T cell lymphomas. Four gp70f-negative lymphomas were negative or only weakly positive with the anti-pl5(E) mAb, whereas one gp70 f-negative lymphoma (2875) was clearly positive . Thus, in summary on all 17 nonresponder tumors, abundant gag and ena expression was found, whereas 10 of 11 responder tumors lacked gag and/or ena determinants on their cell surfaces . b  2456  3  2  2  2  3  3  0  2522  3  2  3  3  3  3  0  2877  3  1  1  1  3  3  0  2554  3  3  0  3  3  3  0  2985  3  2  3  3  3  3  0  3817  3  3  3  3  3  3  0  3846  3  2  2  2  3  3  ND  5167  2  2  2  2  3  3  ND   B10 .A(2R)  k  k  k  b  2508  3  2  2  2  3  3  0  2543  3  2  2  3  3  3  0  2594  3  1  0  3  3  3  ND  2639  3  3  3  2  3  3  0  2648  3  3  3  3  2 H-2D expression, whereas another tumor (3666) had minimal if any detectable H-2K and -D antigens . When tested for the expression of Pgp-1, an antigen that is assumed to be related with the IFN-y producing potential of T cells (45) , these very two tumors showed dull Pgp-1 expression in contrast to the 15 high H-2K-and D-expressing lymphomas, which with one exception (2648) had bright Pgp-1 reactivity (data not shown) . In the series of responder T cell lymphomas, also, the majority (9 of 11 tumors tested) had high H-2K and -D expression . As already mentioned above, one tumor (2558) that, by exception in the responder series, expressed both env and gag viral antigens at the membrane, had no detectable H-2K 6 cells surface antigen, whereas H-2Dd expression was relatively low. One other lymphoma (3993) did not show H-2K b expression but had high Dd expression . This latter Kb-/Dd+ tumor showed bright Pgp-1 expression whereas tumor 2558 (K b-/Ddt) had a relatively dull Pgp-1 expression (data not shown) .
None of the T cell tumors in either series, nonresponder and responder, expressed significant levels of H-2 class II I-A molecules. 
Intracellular Expression of Viral Proteins. We tested a small number of lymphomas for the intracellular presence of viral proteins in an immunofluorescence assay, by incubation of BFA-fixed lymphoma cells with a selected panel of the aforementioned antiviral sera .
First, we showed that, as illustrated for p30-gag in Fig. 2 , after cleavage of the protein of interest at the membrane by trypsin, the intracytoplasmic viral antigen remained detectable . With this method no discrepancies were found between the cell surface and intracellular expression of anti-p30-, anti-pl5Ec-, anti-gp70/pl5E-, and anti-gp70t-reactive viral proteins in tumors 2729, 2769, and 2522 (Tables I and  II) . Thus, the cell surface expression of viral antigens correlated strictly with the presence or absence of these viral antigens intracellularly. Proviral Integrations. T lymphomas of nonresponder and responder mice were analyzed for the presence of newly acquired proviruses. Lymphoma DNAs were cut with Eco RI, which has no restriction site in a full-length ecotropic MuLV provirus and a single site in MCF MuLV at 6.9 kb (46). Hybridizations were carried out with the use of an (MCF and eco-reactive) U3LTR probe and an eco-specific gp70 probe (Fig. 1) . The results (Fig . 3) indicate that both nonresponder and responder with Eco RI and after Southern blotting hybridized first to the MuLV-specific U3LTR probe (A), subsequently to the eco-specific gp70 probe (A), and finally to the N-myc probe (B). Rehybridizations were preceded by rinsing the filter with alkali . DNAs were obtained from tumors numbered as indicated at the top of the lanes. Characteristics of viral and MHC antigen cell surface expression on these tumors are given in Table I (nonresponders) and Table II (responders) . (B)Nmyc rearrangements in two responder T cell lymphomas. Control, B10 liver DNA. The 31-kb Eco RI virus-reactive fragment (A) represents theendogenous ecotropic provirus of C57BLmice, the 3 .4-kb fragment seen in the U3LTR hybridization unfortunately is due to plasmid contamination of the control liver DNA, as was concluded from itshybridization to a large panel ofplasmidcontaining probes (data not shown) .
T cell lymphoma DNAs contained multiple, predominantly MCFlike proviruses. A few exceptions were observed; e.g., tumor 2729 seems to contain only one extra clonal fragment (N20 kb) reactive with both MuLV probes, indicating its ecotropic origin . In search of possible oncogene rearrangements due to proviral integrations, we hybridized Eco RI-digested lymphoma DNAs with a panel of oncogene probes ; we found no c-myc rearrangements, but in two nonresponder lymphomas (2894 and 3666) and three responder lymphomas (2402, 2498, and 2875), pim-1 rearrangements were found (data not shown) . N-myc rearrangements were detected in one nonresponder tumor (3846) (data not shown) and two responder tumors (2729 and 2997) (Fig. 3 B) . The pim-1-and N-myc-reactive rearranged fragments comigrated with U3LTR-reactive DNA fragments, probably indicating that the oncogene rearrangements were due to proviral integrations nearby.
RNA Analyses . To reveal whether the absence of particular viral antigens at the cell surface of responder T cell lymphomas was correlated with quantitative or qualitative changes in viral RNA species found in the tumor cells, we performed Northern blot analyses for a small number of lymphomas (Fig . 4) . We had to make use of first transplant generation tumors, because primary tumor tissues had not been conserved adequately for RNA isolation procedures . The phenotypes of these syngeneic in vivo passaged lymphomas remained completely stable (shown for 2769 in Fig.  5 ). Various probes hybridizing to U3LTR, p15E, and gp70, and gag sequences of MCF and/or ecotropic origin (Fig. 1) were used . Four nonresponder T cell lymphomas, bearing gag and env antigen at their cell surfaces, showed high amounts of viral RNAs of the expected sizes: 8.2-kb genomic RNA, from which the gag and pol products are ultimately derived and 3.2-kb spliced mRNA, which yields the env products (6) . In contrast, only minimal amounts ofboth 8.2-and 3.2-kb RNAs were found in two responder T cell lymphomas, in various individual transplants.
In tumor 2729, which at the cell surface had moderate env, but no detectable gag expression, an aberrant RNA of 2 .5 kb was found, which hybridized only to the U3LTR probe but not to (eco-and MCFspecific) p15(E), gp70, andgag probes ( Fig.  4 ; gag hybridization shown in Fig. 6 ). In this tumor a rearrangement of the N-myc gene, due to proviral integration, had been found (Fig . 3 B) . Reasoning that this proviral integration might influence N-myc transcription, we hybridized 2729 RNA with the N-myc probe (Fig. 4 B) . Indeed, the U3LTR-reactive 2.5-kb RNA in tumor 2729 hybridized also to the N-myc probe. In tumor 2769, on the cell surface ofwhich no gag and only weak gp70e env antigens were detected, an aberrant RNA (4 kb) was found as well ; this RNA hybridized to both the U3LTR and p15(E) probes, but not to gp70 env and gag probes ( Fig. 4 ; gag hybridization shown in Fig. 6 ) . Thus, both quantitative and qualitative differences in viral RNAs were observed when we compared nonresponder and responder lymphomas. The absence ofcell surface viral antigen expression correlated with low amounts of normal viral RNA species.
Involvement of T Cell Reactivity.
The findings thus far strongly suggested that the absence of particular env and/or gag proteins on the tumor cell surface is only required in the face of a class II-regulated T cell response in H-2 I-A responder type mice. Therefore, it seemed ofinterest to determine whether the "virus-negative" variant T cell tumors would re-express env and/or gag proteins iftransplanted in T cell-deficient nu/nu mice. We transplanted two responder T cell tumors, tumor 2729 and 2769, in C57BL/6 nu/nu mice, and studied virus expression in the transplants at the pro- Table I (nonresponders, lanes 1-4) and Table II (responders, lanes tein and the RNA level (Figs. 5 and 6 ). Tumor 2729 retained its virus-negative variant profile upon transplantation in nu/nu mice . The two individual transplants in nu/nu mice of tumor 2769 clearly expressed env antigens, whereas a minority of the lymphoma cells also expressed gag antigens at the cell surface, in contrast to the primary tumor (Fig . 5) . At the RNA level (Fig. 6 ) these cell surface phenomena correlated with the appearance of higher amounts of normal 8. Table I , on the primary tumor 2729 in Table II . The antigenic profiles of the in vivo passaged tumors used for RNA analysis were identical to that of the primary tumors. Analyses of viral and MHC antigen cell surface expression on primarytumor 2769 and subsequent passages into syngeneic and C57BL/6 nu/nu mice are shown in Fig. 5 .
TCR /3 chain gene rearrangement as the parental tumor cells. Moreover, the proviral integration patterns of the primary tumors were identical to those of the transplants for lymphomas 2729 and 2769, passaged in either immunocompetent or nu/nu mice (data not shown) .
Discussion In this study we have documented a major mechanism by which primary immunogenic MuLV induced T cell tumors can be envisaged to evade T cell immunosurveillance, namely by failure to express particular viral antigens at the tumor cell sur-face . More rarely, the absence of class I MHC antigens was observed . Absent viral or MHC class I antigen expression on tumor cells appears only necessary for tumor survival in the face of a strongly Th-dependent antiviral immune response. This conclusion follows from a detailed comparison of viral ena/gag and MHC class I antigen cell surface expression in MCF 1233 MuLV induced T cell lymphomas in H-2 I-A responder and H-2 I-A nonresponder mice .
The absence of p30-reactive cells in 6 of 11 lymphomas of the responder group probably reflects the complete absence of any gag proteins in these lymphoma cells, since the anti-p30 polyclonal serum used reacts with both p30 and its precursor polyproteins (own unpublished results) . In view of the well-known heterogeneity of viral gp70 antigens (47, 48) and the reactivity of polyclonal anti-gp70 sera with gp70-like determinants or normal lymphoid cells (49) , the use of mAb anti-gp70f (reactive with a highly conserved gp70 epitope) is most appropriate for the comparative serological analyses of gp70-env expression on responder and nonresponder lymphomas.
It should be stressed that in the protection against early T cell lymphomas, H-2 I-A-restricted Th may exert both direct effects, such as the production of lymphokines (e .g ., IFN -'Y), and indirect effects, such as the production of anti-MuLV antibodies by B cells and/or the augmentation of MuLV specific Tc activity. We have documented previously that responder mice, in contrast to nonresponder mice, develop high titers of anti-MuLV antibodies (25) . The antibody response to MuLV is known to be directed primarily at the envelope proteins gp70 and p15(E) (50) . Thus, antibody-dependent cellular effector mechanisms in responder mice will probably fail in the absence of these viral antigens . In addition, data of Nowinski et al . (37) , who reported that the anti-gp70f mAb was the only one among the panel anti-gpa -f mAbs that neutralized MuLV, may indicate that selectively the gp70 f determinant is an important envelope epitope in the humoral anti-MCF 1233 immune response .
Although we have no direct evidence for a protective role of MCF1233-specific Tc activity, in view of many other reports (3, summarized in reference 4), it seems very likely that augmentation of Tc responses by the H-2 I-A-restricted anti-MCF1233 Th response will contribute to the eradication of MCF1233-infected cells. Obviously, no reliable quantification of the amount of viral antigen relevant for T cell immunity can be based on serological membrane fluorescence studies. However, it can be envisaged that, if viral proteins are not detectable serologically, no viral ena and/or gag proteins will be available for processing into viral peptides that can be recognized by T cells. Importantly, as discussed below, differences in viral antigen expression detected by serological methods correlated with viral RNA levels in responder and nonresponder lymphomas.
We did not perform immunoprecipitation studies for the quantification of viral proteins for several reasons. First, primary lymphomas would have to be kept in culture, thus, theoretically creating the opportunity for the occurrence of in vitro phenomena such as reexpression of transcriptionally silent proviral genes, which is a real danger in view of data of several groups (6, 20) . Furthermore, membrane fluorescence studies may reveal changes in viral antigen expression that are of importance to antiviral immunity, which cannot be detected by methods in which the natural configuration of viral antigens in the cell membrane is first destroyed by the use of detergents .
As stated already, both ena-negative and gag-negative variants are detected among responder T cell lymphomas, but there seems to be no preferential loss ofa particular antigen in relation to H-2K or -D allelic specificities. This is in line with data ofPlata et al. (9), who demonstrated the presence ofboth gag and ena AKR Gross MuLVspecific Tc in C57BL/6 (H-2b) mice. Moreover, the frequency of gag and ena-specific Tc varied within a given immunized mouse strain (F. Plata, personal communication). Pala et al. (51) reported that the frequency of influenza nucleoprotein-specific Tc varied between individuals of an inbred mouse strain . The immune response against MCF 1233 in H-2 I-Ab mice will be polyclonal but probably is biased to particular gag or ena antigens, dependent on the immunodominance of these antigens in the original presentation to class II-restricted Th. Thus, loss ofena or gag expression can contribute to a relative, but not an absolute, growth advantage for a preleukemic cell .
Other reports of MuLV induced tumors, which lack viral antigen expression, indicate various immunorelevant target molecules (20, (52) (53) (54) . It should be stressed that our observations concerning viral antigen and MHC expression on lymphomas were made on fresh or cryopreserved viable cell suspensions from primary lymphomas that arose in vivo in nonmanipulated animals. The few previous observations ofabsent viral antigen expression on retrovirus-induced lymphomas were made with in vitro tumor lines (52) (53) (54) , or after artificial immunoselective pressure (20) . Green and Manjunath and colleagues (52, 53) described two variant subclones of a tumor cell line, derived from an AKR virus-induced lymphoma in AKR (H-2k) mice, that were resistant to lysis by virus-specific Tc. These variants showed strongly reduced gp70 ena viral antigen expression as detected by the gp70-specific mAb panel, also used here. In line with our data, Green (52) Another study to be discussed in relationship to our data is that of Wolfe et al. (55) , in which the infectious virus production in vitro of Friend MuLV-induced tumor cell lines depended on their H-2 types. Remarkably, for unstated reasons, the viral replication grade decreased in vitro in the absence of immune effector function . Although we can not exclude that such a phenomenon also occurs in vivo in MCF 1233-infected H-2 I-Ab responder type cells, this is unlikely in view of previous results. We have described earlier that MCF 1233 MuLV initially infects thymocytes in both responder and nonresponder mice, as tested by the cell surface expression of Hy-13-reactive ena viral proteins . However, in responder mice virus-infected cells disappear from the thymus, coinciding with the appearance of anti-MuLV antibodies, the production of which requires an adequate class II-regulated Th response. This observation has prompted us to hypothesize that T cell immune reactivity in H-21-Ab mice directly or indirectly clears the viral infection of thymocytes (25) .
The significance of low or absent H-2K and -D expression in two nonresponder T cell lymphomas is not clear. It cannot be excluded that helper-independent Tc may play a minor protective role in H-2I-A nonresponder type mice (25, 56) . We describe here one MCF 1233-induced T cell lymphoma (2558) in the responder series that shows selective loss of Kb expression with only weak Dd expression . Remarkably, this tumor was the only exception in the responder series with respect to the expression of viral ena and gag proteins, which were easily detectable in this tumor. Another lymphoma, 3933, lacked Kb expression and showed normal ena but absent gag expression. We previously showed that the immune response against MCF 1233 is primarily I-A-regulated Th dependent (25) . The relative contribution of class I-restricted Tc responses in the eradication of virus-infected cells has not yet been clarified. Interestingly, the exceptional switch offof class I H-2K expression was observed in both cases for B10 .A(5R) lymphomas (H-2Kb , -I-Ab , -Dd) . At this moment it remains speculative whether this observation indicates an important role for Kb as sole restriction element if no Db is available. Plata et al. (9) demonstrated that B6 mice recognize both gag and ena gene products of Gross (AKR type) MuLV efficiently in association with Kb or Db.
It seemed of interest to determine at which level the absence of particular viral proteins at the cell membrane of responder T lymphoma cells was established. To this end, we studied two responder T cell lymphomas (2729 and 2769) in more detail. The direct serological measurement of the intracellular presence of viral proteins after fixation in BFA of the T lymphoma cells did not show discrepancies between membrane and intracytoplasmic expression .
In T cell lymphoma DNAs ofboth nonresponder mice and responder mice (Fig.  3) , multiple newly acquired proviruses could be detected with an U3LTR probe. However, it should be noted that this does not take into account whether or not these integrations represent full-length, partially deleted, or defective proviruses. Insertional mutagenesis, a well-documented oncogenic mechanism in MuLV induced T cell lymphomas (57) (58) (59) , only requires the activity of proviral LTR sequences (60) . More extensive analyses of the nature of the viral reintegrations in nonresponder and responder lymphomas is hampered by the presence of multiple MCF and xenotropic-like endogenous viral sequences (6, 61) .
The amount of viral RNAs (8.2 and 3.2 kb) in two responder T cell lymphomas (2729 and 2769) was only minimal when compared with that in four nonresponder T cell lymphomas. The expression of proviruses is known to be influenced by a number of factors. A causal relationship between hypermethylation and gene inactivity has been established for retroviral genomes (20, 62) . Moreover the host integration site and specific sequences within the long terminal repeat (LTR) may regulate the viral expression (6) . One possibility to be considered in our study is that in H-2I-A responder type mice, only tumor cells that harbor proviruses that do not yield immunorelevant viral proteins but have retained transformational capacities due to insertional mutagenic effects of integrated LTRs will grow out. In this respect, it is of note that the mean latency of T cell tumors in the responder strains (57 wk) is significantly longer than in the nonresponder mice (37 wk) (25) . This may reflect the time needed to require the extra and rare conditions required to grow out in the presence ofan antiviral immune response. In both responder tumors (2729 and 2769) abnormally sized viral RNAs are found. In tumor 2729 the single proviral integration near N-myc apparently results in the expression of a 2.5-kb RNA, containing U3LTR and N-myc sequences. It is possible that LTRenhanced transcrip-tion ofN-myc interferes with transcription ofproviral DNA, thus explaining decreased virus expression in tumor 2729 . The origin ofthe aberrant viral RNA found in tumor 2769 remains to be determined.
The stable virus-negative phenotype of tumor 2729 upon in vivo passage in T cell-deficient nu/nu mice is compatible with interference of N-myc and provirus transcription within this tumor, as stated above. However, tumor 2769 re-expressed both viral ena and gag proteins upon transplantation in nu/nu mice . Importantly, at the DNA level no obvious changes could be detected with respect to viral integration pattern in the various transplants. This argues against the outgrowth ofa pre-existing minor subpopulation of virus-positive cells. Obviously, no general conclusions can be drawn from the limited transplantation data of tumor 2769 ; more experiments are now in progress to determine how generally the seesaw phenomenon occurs in the absence or presence of T cell immunity. At this moment it is merely speculative which mechanism(s) underlie the re-expression ofviral antigens in lymphoma 2769 . Noteworthy, no significant differences in macroscopic aspect and/or latency (4 wk) of the transplants were observed, whether they grew out in immunocompetent or deficient mice . One possibility is that in immunocompetent mice, MuLV specific Th produce IFN-y, which is known to downregulate the expression of proviral genes (63) .
It should be mentioned that we found no strict direct quantitative relationship between the amounts of viral RNA and the presence of particular viral antigens at the tumor cell surface, detected serologically. Tumor 2429 does express gp70 epitopes, whereas only a minimal amount of ena probe-reactive RNAs is present. The data discussed thus far indicate that both quantitative and more subtle qualitative changes in viral antigen expression are found in distinct responder T cell tumors .
Our observations on MuLV induced lymphomagenesis may have important implications for the understanding of the pathogenesis of human virus-induced disease. A study of Massuci et al . (64) shows that certain Burkitt lymphoma cell lines that are resistant to EBVspecific Tc have selectively lost expression of EBVencoded latent membrane protein, in addition to loss ofHLA-All expression, suggesting that this mechanism of low viral antigen and/or MHC expression may also operate in man. It is tempting to draw a parallel between our results and those of two recent studies (65, 66) , which show that progression of disease in individuals infected with HIV-1 is correlated with the emergence of HIV-1 variants that are more cytopathic and replicate to a higher titer in a wide variety of different human cells. It has been suggested that the infectivity ofdifferent HIV virus isolates is established at the transcriptional level. In our view, and as is illustrated by our results, it could well be that these HIV variants emerge as a consequence ofthe dynamic molecular genetic features of retroviral infection and its close interaction with the host-determined immune response. Summary T lymphoma induction by the mink cell focus-inducing murine leukemia virus MCF 1233 in C57BL/10 and C57BL/6 mice is influenced by a strongly Th-dependent, H-2I-A-restricted antiviral immune response (25) . We compared the MHC class I as well as viral ena and gag antigenic cell surface profiles of frequent T lymphomas ofH-2I-A nonresponder-type mice to that ofrare T lymphomas of H-2I-A responder-type mice. Membrane immunofluorescence studies, with a panel of anti-ena mAbs (reactive with the highly conserved gp70f epitope, the p15E`epitope, and the gp70-p15E complex), a polyclonal anti-p30 serum, and anti-H-2 class I mAbs, showed that all 17 nonresponder tumors tested expressed high levels of both ena and gag viral proteins, and 15 of these 17 nonresponder tumors expressed high levels of H-2 class I K and D antigens. In contrast, 10 of 11 responder lymphomas lacked ena and/or gag determinants. The only responder lymphoma with both strong ena and gag expression failed to express H-2K and -D antigens. Preferential loss of ena or gag expression did not correlate with H-2 class I allelic specificities .
Both responder and nonresponder T lymphoma DNA contained multiple, predominantly MCRlike, newly acquired proviral integrations. Differences in viral antigen cell surface expression were confirmed at cytoplasmic and RNA levels . The amounts of 8.2-and 3.2-kb viral RNA were greatly reduced in two responder lymphomas when compared with four nonresponder lymphomas . In both responder lymphomas, aberrantly sized viral RNA species were found. Upon in vivo passage ofthese responder lymphomas in either immunocompetent or T cell-deficient nu/nu mice, it was found that various molecular mechanisms may underlie the lack ofviral antigen expression at the cell surface ofthese lymphomas . One lymphoma re-expressed viral antigens when transplanted with nu/nu mice, whereas the other remained stably gag negative . The combined findings indicate that an H-2I-A-regulated antiviral immune response not only strongly reduces T lymphoma incidence, but also forces T lymphomas that still arise to poorly express viral antigens, thus explaining their escape from immunosurveillance.
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